{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:39:22Z","timestamp":1779309562469,"version":"3.51.4"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2021,11,19]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cognitive dysfunction in SLE is common and associated with significant morbidity but is currently underdetected. Early detection requires the use of screening tests, as formal diagnostic cognitive testing is time-consuming. This study aims to evaluate the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysfunction in SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with SLE (n=95) and demographically matched healthy control participants (n=48) underwent cognitive testing using the 1-hour neuropsychiatric test battery recommended by the American College of Rheumatology for use in SLE and the MoCA. We used regression analyses to determine associations between MoCA and cognitive test scores. We assessed several MoCA cut-offs for predicting cognitive impairment in terms of sensitivity, specificity, positive predictive value and negative predictive value. Receiver operating curve analyses were used to determine the diagnostic accuracy of the MoCA cut-off thresholds.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found a significant correlation between MoCA score and 9 of the 10 cognitive endpoints studied (all p&lt;0.001). Receiver operating curve analysis suggested that a MoCA cut-off of &lt;27 had highest diagnostic accuracy across the cognitive impairment definitions (area under the curve 0.76\u20130.78). Using a screening cut-off of &lt;28, the MoCA had sensitivity of 83%\u201394% and specificity of 46%\u201359%, depending on the impairment definition used.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The MoCA correlates strongly with cognitive test results in SLE and has sufficient sensitivity for use as a screening tool with a cut-off of &lt;28 as the optimal threshold. This tool can be incorporated into clinical practice for screening for cognitive dysfunction in SLE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2021-000580","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T11:50:27Z","timestamp":1639569027000},"page":"e000580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-7328","authenticated-orcid":false,"given":"Sudha","family":"Raghunath","sequence":"first","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Rheumatology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifat","family":"Glikmann-Johnston","sequence":"additional","affiliation":[{"name":"Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-3338","authenticated-orcid":false,"given":"Eric","family":"Morand","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Rheumatology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie C","family":"Stout","sequence":"additional","affiliation":[{"name":"Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-7383","authenticated-orcid":false,"given":"Alberta","family":"Hoi","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Rheumatology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"2025091514150585000_8.1.e000580.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.8.1214"},{"key":"2025091514150585000_8.1.e000580.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.02.007"},{"key":"2025091514150585000_8.1.e000580.3","unstructured":"Arntsen K , Wildman P , Gross D . Lupus: patient voices. joint report by lupus research alliance, lupus Foundation of America and lupus and allied diseases association for the CDER and FDA. 2018 6 March 2018. Available: http:\/\/www.lupuspfdd.org\/LupusPFDDReportwCover.pdf"},{"key":"2025091514150585000_8.1.e000580.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.23090"},{"key":"2025091514150585000_8.1.e000580.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.24346"},{"key":"2025091514150585000_8.1.e000580.6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310382430"},{"key":"2025091514150585000_8.1.e000580.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111504"},{"key":"2025091514150585000_8.1.e000580.8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1017\/S1355617718000073","article-title":"Cognitive impairment in patients with neuropsychiatric and Non-neuropsychiatric systemic lupus erythematosus: a systematic review and meta-analysis","volume":"24","author":"Zabala","year":"2018","journal-title":"J Int Neuropsychol Soc"},{"key":"2025091514150585000_8.1.e000580.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2025091514150585000_8.1.e000580.10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/RHU.0000000000000876","article-title":"The Montreal cognitive assessment test: a useful tool in screening of cognitive impairment in patients with systemic lupus erythematosus","volume":"25","author":"Paez-Venegas","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"2025091514150585000_8.1.e000580.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161125"},{"key":"2025091514150585000_8.1.e000580.12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311405374"},{"key":"2025091514150585000_8.1.e000580.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091366"},{"key":"2025091514150585000_8.1.e000580.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.20692"},{"key":"2025091514150585000_8.1.e000580.15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/acr.24096","article-title":"Validity evidence for the use of automated neuropsychologic assessment metrics as a screening tool for cognitive impairment in systemic lupus erythematosus","volume":"72","author":"Tayer-Shifman","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2025091514150585000_8.1.e000580.16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5694\/mja16.01282","article-title":"The Australian lupus Registry and Biobank: a timely initiative","volume":"206","author":"O'Neill","year":"2017","journal-title":"Med J Aust"},{"key":"2025091514150585000_8.1.e000580.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"2025091514150585000_8.1.e000580.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025091514150585000_8.1.e000580.19","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000372"},{"key":"2025091514150585000_8.1.e000580.20","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.246280"},{"key":"2025091514150585000_8.1.e000580.21","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"2025091514150585000_8.1.e000580.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780391213"},{"key":"2025091514150585000_8.1.e000580.23","first-page":"215","article-title":"L'examen psychologique dans les cas d'enc\u00e9phalopathie traumatique. (Les problems.) [The psychological examination in cases of traumatic encepholopathy. Problems]","volume":"28","author":"Rey","year":"1941","journal-title":"Archives de Psychologie"},{"key":"2025091514150585000_8.1.e000580.24","doi-asserted-by":"crossref","unstructured":"Delis DC , Kramer JH , Kaplan E . California verbal learning Test-3. 3rd edn. San Antonio: TTPC, 2017.","DOI":"10.1037\/t79642-000"},{"key":"2025091514150585000_8.1.e000580.25","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(69)90057-4"},{"key":"2025091514150585000_8.1.e000580.26","first-page":"1","volume-title":"Wechsler adult intelligence scale","volume":"22","author":"Wechsler","year":"2008"},{"key":"2025091514150585000_8.1.e000580.27","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.390"},{"key":"2025091514150585000_8.1.e000580.28","unstructured":"Strauss E , Sherman EM , Spreen O . A compendium of neuropsychological tests: administration, norms, and commentary. American Chemical Society, 2006."},{"key":"2025091514150585000_8.1.e000580.29","unstructured":"Wechsler D . The test of premorbid function (TOPF). San Antonio, TX: Corporation. TP, 2011."},{"key":"2025091514150585000_8.1.e000580.30","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307079044"},{"key":"2025091514150585000_8.1.e000580.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.10561"},{"key":"2025091514150585000_8.1.e000580.32","first-page":"773","article-title":"Optimal cutoffs for the Montreal cognitive assessment vary by race and ethnicity","volume":"10","author":"Milani","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025091514150585000_8.1.e000580.33","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.004726"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2021-000580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:15:16Z","timestamp":1757970916000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2021-000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,15]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/lupus-2021-000580"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2021-000580","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}